SONNET BIOTHERAPEUTICS HOLDI (SONN) Stock Cash Flow
NASDAQ:SONN - Nasdaq - US83548R4020 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-9-30) | 2023 (2023-9-30) | 2022 (2022-9-30) | 2021 (2021-9-30) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -13.29M | -7.44M | -18.83M | -29.72M | -24.98M | |||
| Depreciation Amortization | 121.00K | 83.10K | 75.80K | 10.00K | 10.00K | |||
| Change In Working Capital | 525.00K | -1.87M | -3.12M | 90.00K | 1.09M | |||
| Interest Paid | N/A | N/A | N/A | N/A | N/A | |||
| Taxes Paid | N/A | N/A | N/A | N/A | N/A | |||
| Other non cash items | 1.02M | 615.30K | 530.60K | 1.93M | 1.33M | |||
| OPERATING CASH FLOW | -11.62M | -8.61M | -21.34M | -27.69M | -22.55M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | -12.00K | -443.30K | -900.00K | 0.00 | |||
| Other Investing Activity | N/A | N/A | N/A | N/A | N/A | |||
| INVESTING CASH FLOW | N/A | -12.00K | -443.30K | -900.00K | 0.00 | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | -800.00 | 0.00 | -20.00K | |||
| Stock Issued/Repurchased | 10.73M | 6.88M | 21.01M | 4.01M | 42.85M | |||
| Other Financing Activity | -815.60K | -385.40K | N/A | N/A | 0.00 | |||
| FINANCING CASH FLOW | 9.92M | 6.49M | 21.01M | 4.01M | 42.83M | |||
| Exchange Rate Effect | N/A | N/A | N/A | N/A | N/A | |||
| CHANGE IN CASH | -1.73M | -2.12M | -778.60K | -24.58M | 20.28M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -11.62M | -8.61M | -21.34M | -27.69M | -22.55M | |||
| Capital Expenditure | N/A | -12.00K | -443.30K | -900.00K | 0.00 | |||
| FREE CASH FLOW | -11.65M | -8.62M | -21.79M | -28.59M | -22.55M | |||
All data in USD